Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More The Motley Fool 23:12 Sat, 24 Oct
Gene therapy offers to beat hepatitis B virus by muting its DNA The Hindu 4d Genetics DNA Science Article paywall All sources
Casgevy gains UK label expansion for younger patient population Pharmaceutical Technology 2d CRISPR Therapeutics Sickle Cell Disease All sources
CRISPR prime editing rewrites DNA in the human body for the first time Singularity Hub 3d DNA Genetics Science All sources
Custom gene-Editing therapies for rare diseases could win faster approvals under FDA draft plan, not yet final Medical Daily 2d Rare Diseases Biology
